Key result
Hybrid EP-guided thoracoscopic ablation eliminates residual pathologic substrate in a Brugada syndrome patient with recurrent VT.
Why the study?
Does hybrid electrophysiology-guided video-assisted thoracoscopic ablation prevent ventricular tachycardia recurrence in a patient with Brugada syndrome and prior failed percutaneous epicardial ablation?
Case Report (n=1)
Does hybrid electrophysiology-guided video-assisted thoracoscopic ablation prevent ventricular tachycardia recurrence in a patient with Brugada syndrome and prior failed percutaneous epicardial ablation?
Hybrid thoracoscopic epicardial ablation may be an effective strategy for patients with Brugada syndrome and recurrent ventricular tachycardia after failed percutaneous epicardial ablation.
A 38-year-old man with a diagnosis of Brugada syndrome had a recurrence of monomorphic ventricular tachycardia 6 years after successful epicardial right ventricular outflow tract ablation by the use of subxiphoid access. Preprocedural and intraprocedural investigations suggested that the pathologic substrate of the right ventricular outflow tract had not been eliminated completely. Therefore, the patient underwent a hybrid electrophysiology-guided video-assisted thoracoscopic ablation. (Level of Difficulty: Advanced.)
No takes yet. Share an insight, caveat, or question.
Eltsov et al. (2022) conducted a case report in Brugada syndrome with recurrent ventricular tachycardia (n=1). Hybrid electrophysiology-guided video-assisted thoracoscopic ablation was evaluated. A 38-year-old man with Brugada syndrome and recurrent ventricular tachycardia underwent hybrid electrophysiology-guided video-assisted thoracoscopic ablation to eliminate residual pathologic substrate.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: